bpc-157 typical human dosage BPC 157: Science-Backed Uses, Benefits, Dosage, and Safety bpc-157 human clinical trial dose

Hum Reprod Open

& Lam, E

Retrieved May 6, 2025, from SkinKraft

(1999) demonstrated the wound-healing effects of TB-500, already known for its angiogenic properties

Genie out of the bottle

Doses used in ARA-290 human trials Study context Sarcoidosis pilot (2012) Dose & route 2 mg IV Schedule 3x/week, 4 weeks Study context Sarcoidosis SFN (2013) Dose & route Daily subQ Schedule 28 days Study context Type 2 diabetes neuropathy (2014) Dose & route 4 mg subQ Schedule Daily, 28 days Study context Phase 2b sarcoidosis (2017) Dose & route 1, 4, or 8 mg subQ Schedule Daily, 28 days Study context Diabetic macular edema (2020) Dose & route 4 mg subQ Schedule Daily, 12 weeks This is trial reporting, not a dosing recommendation